Mobius Medical

A full-service clinical research partner with operations in the United States, Australia, and New Zealand with staff based globally.

Your Success is our Success

Mobius Medical is a top tier, full service clinical research partner offering a customized service with unparalleled responsiveness. Owner operated, Mobius has operations throughout the United States, Australia and New Zealand, and staff based globally.

With a well-established, ISO:9001-certified Quality Management System, you can rely on our comprehensive standard operating procedures and processes.

“Better Together”

Mobius has a 15 year strong, proven track record for delivering a top class service for our clients, working closely with key stakeholders every step of the way

Our people are our greatest asset. Mobius prides itself on a long-term team of talented, caring professionals. Staff retention is crucial to us.

Full service or a la carte – our flexible approach is one that will be tailored to your exact needs, no matter the size of your project.

What they Say About Mobius

Consider Australia
Choose Mobius Medical

Local Sponsor

Therapeutic Goods Administration (TGA) mandates that an Australian entity sponsors ALL clinical trials.
Mobius acts as local Australian sponsor on behalf of our overseas clients.

This responsibility includes:

  • Contractual arrangements for sites
  • Indemnity, site payments
  • Safety reporting responsibility to TGA

Speed of Start up

Australia’s TGA operates an expeditious on-line notification scheme, following approvals from ethics committee and local institution (or health authority).

Medical device trials are not regulated in New Zealand and only ethics/institutional approval are required.

Pharma studies do require NZ regulatory approval from SCOTT.

Cost Savings

Mobius works diligently to deliver nimble, efficient services that save time and money for our clients. Our EDC, and supplementary options such as ePRO/dairy, IWRS is built in-house saving our clients costs associated with EDC vendors.

Clinical trials conducted in Australia are fully eligible for the Australian R+D tax program which provides cash rebates of up to 43c for each $ spent.

Schedule a Meeting with us